Opinion statement
Merkel cell carcinoma is a rare cutaneous neoplasm most commonly affecting the head and neck of elderly white patients. Even with treatment, Merkel cell carcinoma has a strong propensity toward local recurrence, lymphatic spread, and distant metastasis. Because of its rarity and the subsequent lack of well-controlled clinical trials, no single standard of care exists for the treatment of this aggressive tumor. In our institution, primary lesions are excised with wide margins or by Mohs’ micrographic surgery. After local removal, the excision site is treated locally with external radiation therapy. Sentinel lymph node mapping and biopsy are performed. Patients with tumor within a sentinel lymph node undergo lymph node dissection and radiation to the lymphatic basin. Adjuvant chemotherapy is offered to high-risk patients with local disease and to patients with metastases. Patients with distant metastases are treated with a combination of salvage chemotherapy and radiation therapy.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Similar content being viewed by others
References and Recommended Reading
Goessling W, McKee PH, Mayer RJ: Merkel cell carcinoma. J Clin Oncol 2002, 20:588–598. This paper is a thorough review, including a strong discussion of the epidemiology, presentation, and basic science of Merkel cell carcinoma.
Angelli M, Clegg LX: Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003, 49:832–841.
Miller RW, Rabkin CS: Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999, 8:153–158.
An KP, Ratner D: Merkel cell carcinoma in the setting of HIV infection. J Am Acad Dermatol 2001, 45:309–312.
Urbatsch A, Sams WM, Urist MM, Sturdivant R: Merkel cell carcinoma occurring in renal transplant patients. J Am Acad Dermatol 1999, 41:289–290.
Lien HC, Tsai TF, Lee YY, Hsiao CH: Merkel cell carcinoma and chronic arsenicism. J Am Acad Dermatol 1999, 41:641–643.
Akhtar S, Oza KK, Wright J: Merkel cell carcinoma: report of 10 cases and review of the literature. J Am Acad Dermatol 2000, 43:755–767.
Medina-Franco H, Urist MM, Fiveash J, et al.: Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol 2001, 8:204–208.
Coit DG: Merkel cell carcinoma. Ann Surg Oncol 2001, 8:99–102.
Skelton HG, Smith KJ, Hitchcock CL, et al.: Merkel cell carcinoma: analysis of clinical, histological, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol 1997, 37:734–739.
Samonis G, Mantadakis E, Kononas TC, et al.: Merkel cell carcinoma: a case series of twelve patients and review of the literature. Anticancer Res 2001, 21:4173–4178.
Lawenda BD, Thiringer JK, Foss RD, Johnstone PA: Merkel cell carcinoma arising in the head and neck: optimizing therapy. Am J Clin Oncol 2001, 24:35–42.
Yiengpruksawan A, Coit DG, Thaler HT, et al.: Merkel cell carcinoma: prognosis and management. Arch Surg 1991, 126:1514–1519.
O’Connor WJ, Brodland DG: Merkel cell carcinoma. Dermatol Surg 1996, 22:262–267.
Ott JM, Tanabe KK, Gadd MA, et al.: Multimodality management of Merkel cell carcinoma. Arch Surg 1999, 134:388–393.
Gillenwater AM, Hessel AC, Morrison WH, et al.: Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001, 127:149–154.
O’Connor WJ, Roenigk RK, Brodland DG: Merkel cell carcinoma: comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg 1997, 23:929–933.
Gollard R, Weber R, Kosty MP, et al.: Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations. Cancer 2000, 88:1842–1851. The discussion section of this small series includes an excellent review of the treatment literature.
Herbst A, Haynes HA, Nghiem P: The standard of care for Merkel cell carcinoma should include adjuvant radiation and lymph node surgery. J Am Acad Dermatol 2002, 46:640–642.
Smith DF, Messina JL, Perrott R, et al.: Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Cancer Control 2000, 7:72–83. In addition to providing an excellent review, this article contains a detailed flow diagram to assist in the management of patients with Merkel cell carcinoma.
Goessling W, McKee PH, Mayer RJ: Merkel cell carcinoma. J Clin Oncol 2002, 2:588–598.
Eich HT, Eich D, Staar S, et al.: Role of postoperative radiotherapy in the management of Merkel cell carcinoma. Am J Clin Oncol 2002, 25:50–6.
Boyer JD, Zitelli JA, Brodland DG, D’Angelo G: Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol 2002, 47:885–892.
Wilder RB, Harari PM, Graham AR, et al.: Merkel cell carcinoma: improved locoregional control with postoperative radiation therapy. Cancer 1991, 68:1004–1008.
Fenig E, Brenner B, Katz A, et al.: The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer 1997, 80:881–885.
Wasserberg N, Schachter J, Fenig E, et al.: Applicability of the sentinel node technique to Merkel cell carcinoma. Dermatol Surg 2000, 26:138–141.
Rodrigues LK, Leong SP, Kashani-Sabet M, Wong JH: Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Dermatol 2001, 45:303–308.
Pan D, Narayan D, Ariyan S: Merkel cell carcinoma: five case reports using sentinel lymph node biopsy and a review of 110 new cases. Plast Reconstr Surg 2002, 110:1259–1265.
Ames SE, Krag DN, Brady MS: Radiolocalization of the sentinel lymph node in Merkel cell carcinoma: a clinical analysis of seven cases. J Surg Oncol 1998, 67:251–254.
Poulsen M, Rischin D, Walpole E, et al.: High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study TROG 96:07. J Clin Oncol 2003, 21:4371–4376.
Meeuwissen J, Bourne RG, Kearsley JH: The importance of post-operative radiotherapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1995, 31:325–331.
Morrison W, Peters LJ, Silva EG, et al.: The essential role of radiation therapy is securing loco-regional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1990, 19:583–591.
Pacell J, Ashby M, Ainslie J, Minty C: The role of radiotherapy in the management of primary cutaneous neuroendocrine tumours: experience of the Peter MacCallum Cancer Institute (Melbourne, Australia). Int J Radiat Oncol Biol Phys 1988, 14:1077–1084.
Wong KC, Zuletta F, Clarke SJ, Kennedy PJ: Clinical management and treatment outcomes of Merkel cell carcinoma. Aust N Z J Surg 1998, 68:354–358.
Haag M, Glass LF, Fenske NA: Merkel cell carcinoma: diagnosis and treatment. Dermatol Surg 1995, 21:669–683.
Smith DF, Messina JL, Perrott R, et al.: Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Cancer Control 2000, 7:72–83.
Goessling W, McKee PH, Mayer RJ: Merkel cell carcinoma. J Clin Oncol 2002, 2:588–598.
Brown TJ, Jackson BA, Macfarlane DF, Goldberg LH: Merkel cell carcinoma: spontaneous resolution and management of metastatic disease. Dermatol Surg 1999, 25:23–25.
Connelly TJ, Cribier B, Brown TJ, Yanguas I: Complete spontaneous regression of Merkel cell carcinoma: a review of the 10 reported cases. Dermatol Surg 2000, 26:853–856.
Plunkett TA, Subrumanian R, Leslie MD, Harper PG: Management of Merkel cell carcinoma. Expert Rev Anticancer Ther 2001, 1:441–445.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lehrer, M.S., Hershock, D. & Ming, M.E. Merkel cell carcinoma. Curr. Treat. Options in Oncol. 5, 195–199 (2004). https://doi.org/10.1007/s11864-004-0011-9
Issue Date:
DOI: https://doi.org/10.1007/s11864-004-0011-9